SEC 13F Intelligence

Managers / Q1 2024 · view latest →

VK Services, LLC

CIK 0001501927 · 2128 SAND HILL ROAD, MENLO PARK, CA, 94025 · (650) 376-8526

Reported Value
$549M
Q1 2024
Positions
7
Filings on Record
30
2019–present window
Filed
May 15, 2024
original filing

Summary

Vk Services, LLC reported $549M in U.S.-listed holdings across 7 positions for Q1 2024.

The portfolio is heavily concentrated: Rocket Lab USA alone accounts for 47.7% of reported value.

Compared with Q4 2023, the fund opened 1 new position and exited 1.

Portfolio Metrics

Turnover
+20.2%
vs prior filed quarter
Largest Position
+47.7%
Rocket Lab USA
New / Exited
1 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $268MQ4 ’18Q1 ’19: $548MQ2 ’19: $617MQ3 ’19: $296MQ4 ’19: $209MQ4 ’19Q1 ’20: $0Q4 ’20: $2.8BQ1 ’21: $4.3BQ2 ’21: $3.0BQ2 ’21Q3 ’21: $4.4BQ4 ’21: $4.6BQ1 ’22: $2.0BQ2 ’22: $671MQ2 ’22Q3 ’22: $671MQ4 ’22: $568MQ1 ’23: $676MQ2 ’23: $880MQ2 ’23Q3 ’23: $750MQ4 ’23: $660MQ1 ’24: $549MQ2 ’24: $410MQ2 ’24Q3 ’24: $455MQ4 ’24: $849MQ1 ’25: $388MQ2 ’25: $770MQ2 ’25Q3 ’25: $404MQ1 ’26: $542,836filingsflow.com

Portfolio Composition

By security type
Other: 59.7%Common Stock: 40.3%
  • Other · 59.7% · $328M
  • Common Stock · 40.3% · $221M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
LANZATECH GLOBAL INCNEW+2.63M2.63M+$43M$43M
OSCROSCAR HEALTH INCSOLD OUT−6.85M0−$63M$0
ROCKET LAB USA INCTRIMMED−11.00M63.75M−$151M$262M
CARTMAPLEBEAR INCHELD+05.60M+$77M$209M
PACBPACIFIC BIOSCIENCES OF CALIFORNIA INCHELD+02.63M−$16M$10M
VICARIOUS SURGICAL INCHELD+028.96M−$2M$9M
VELO3D INCHELD+030.35M+$2M$14M
AFRMAFFIRM HLDGS INCHELD+075.0K−$890,774$3M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2024

7 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ROCKET LAB USA INCCOMMON STOCK47.73%$262M63.75M
2CARTMAPLEBEAR INChistory →COMMON STOCK38.03%$209M5.60M
3LANZATECH GLOBAL INCCOMMON STOCK7.82%$43M2.63M
4VELO3D INCCOMMON STOCK2.52%$14M30.35M
5PACBPACIFIC BIOSCIENCES OF CALIFORNIA INChistory →COMMON STOCK1.80%$10M2.63M
6VICARIOUS SURGICAL INCCLASS A COMMON STOCK1.59%$9M28.96M
7AFRMAFFIRM HLDGS INCCLASS A COMMON STOCK0.51%$3M75.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$542,8361May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025Under review2Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$404M3Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$770M2Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$388M2May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$849M2Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$455M5Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$410M7Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$549M7May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$660M7Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$750M10Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$880M11Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$676M11May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$568M9Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$671M7Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$671M11Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$2.0B10May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$4.6B9Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$4.4B11Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$3.0B7Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$4.3B7May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$2.8B5Feb 16, 202113F-HRchanges · EDGAR ↗
Q1 2020$01May 5, 202013F-HRchanges · EDGAR ↗
Q4 2019$209M1Jan 31, 202013F-HRchanges · EDGAR ↗
Q3 2019$296M1Oct 25, 201913F-HRchanges · EDGAR ↗
Q2 2019$617M1Jul 18, 201913F-HRchanges · EDGAR ↗
Q1 2019$548M1Apr 23, 201913F-HRchanges · EDGAR ↗
Q4 2018$268M1Feb 13, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 3 additional managers.

  • Khosla Ventures Associates IV, LLC028-19200
  • Khosla Ventures Associates V, LLC028-20985
  • Khosla Ventures Seed Associates B, LLC028-20986

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.